Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.
Ann Rheum Dis
; 80(2): 1-2, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-639468
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Receptors, Interleukin-6
/
Antibodies, Monoclonal, Humanized
/
SARS-CoV-2
/
COVID-19 Drug Treatment
Type of study:
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Ann Rheum Dis
Year:
2021
Document Type:
Article
Affiliation country:
Annrheumdis-2020-218243
Similar
MEDLINE
...
LILACS
LIS